JAK3/BTK-IN-5

Modify Date: 2024-04-03 10:57:50

JAK3/BTK-IN-5 structure	Common Name	JAK3/BTK-IN-5
	CAS Number	2673196-75-1	Molecular Weight	415.88
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉H₂₂ClN₇O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of JAK3/BTK-IN-5

JAK3/BTK-IN-5 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-5 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 35)[1]

Name	JAK3/BTK-IN-5

Description	JAK3/BTK-IN-5 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-5 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 35)[1]
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
References	[1]. Baoguo Zhang, et al. Pyrimidinopyrimidine and pentacyclic derivatives and their applications. Patent WO2021147953A1.

Molecular Formula	C₁₉H₂₂ClN₇O₂
Molecular Weight	415.88

JAK3/BTK-IN-5

Use of JAK3/BTK-IN-5

Names

JAK3/BTK-IN-5 Biological Activity

Chemical & Physical Properties